BioCentury
ARTICLE | Financial News

Gilead sells note deal

December 14, 2000 8:00 AM UTC

Infectious disease and cancer company GILD raised $250 million through the sale of convertible subordinated notes, which have seven-year term, bear 5 percent interest, and convert into GILD common sto...